Total Payments
$5,479
2024 Payments
$735.60
Companies
29
Transactions
280
Medicare Patients
2,684
Medicare Billing
$490,546
Payment Breakdown by Category
Food & Beverage$5,279 (96.3%)
Other$124.99 (2.3%)
Education$75.00 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,279 | 273 | 96.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $124.99 | 1 | 2.3% |
| Education | $75.00 | 6 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Organogenesis Inc. | $1,424 | 20 | $0 (2023) |
| Smith+Nephew, Inc. | $901.90 | 48 | $0 (2024) |
| ABBVIE INC. | $489.05 | 48 | $0 (2024) |
| Merck Sharp & Dohme LLC | $430.82 | 32 | $0 (2024) |
| KCI USA, Inc. | $348.49 | 6 | $0 (2020) |
| ViiV Healthcare Company | $316.56 | 16 | $0 (2024) |
| Melinta Therapeutics, LLC | $301.60 | 20 | $0 (2024) |
| Allergan, Inc. | $232.10 | 28 | $0 (2020) |
| Theravance Biopharma, Inc. | $209.55 | 17 | $0 (2018) |
| Insmed, Inc. | $132.82 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $735.60 | 33 | Smith+Nephew, Inc. ($206.81) |
| 2023 | $856.08 | 34 | Smith+Nephew, Inc. ($287.17) |
| 2022 | $662.00 | 45 | Smith+Nephew, Inc. ($225.17) |
| 2021 | $687.86 | 41 | ORGANOGENESIS INC. ($290.68) |
| 2020 | $375.29 | 21 | ViiV Healthcare Company ($79.84) |
| 2019 | $833.86 | 24 | Organogenesis Inc. ($480.13) |
| 2018 | $570.33 | 27 | KCI USA, Inc ($238.21) |
| 2017 | $757.98 | 55 | Organogenesis Inc. ($208.51) |
All Payment Transactions
280 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Other Advanced Wound Management | ||||||
| 12/19/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: GI | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/09/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $14.17 | General |
| 11/26/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $36.32 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: HIV | ||||||
| 11/07/2024 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/22/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: HIV | ||||||
| 10/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: VIROLOGY | ||||||
| 10/01/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/12/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: ANTIFUNGALS | ||||||
| 09/10/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $10.40 | General |
| Category: Wound Care | ||||||
| 08/29/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: GI | ||||||
| 08/25/2024 | BSN Medical Inc | CUTIMED (Device) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: WOUND CARE | ||||||
| 07/20/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Other Advanced Wound Management | ||||||
| 07/18/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: GI | ||||||
| 07/18/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Pharma Products | ||||||
| 07/09/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: HIV | ||||||
| 06/21/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: VIROLOGY | ||||||
| 06/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: ANTIBIOTIC | ||||||
| 05/07/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/25/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 605 | 2,044 | $315,855 | $110,650 |
| 2022 | 11 | 649 | 2,031 | $317,093 | $124,403 |
| 2021 | 12 | 691 | 2,084 | $311,462 | $130,047 |
| 2020 | 14 | 739 | 2,189 | $309,674 | $125,446 |
Total Patients
2,684
Total Services
8,348
Medicare Billing
$490,546
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 105 | 621 | $74,520 | $30,969 | 41.6% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 86 | 440 | $117,920 | $19,999 | 17.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 84 | 230 | $27,370 | $14,380 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 96 | $16,320 | $8,196 | 50.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 52 | 59 | $17,700 | $8,036 | 45.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 47 | 106 | $18,020 | $7,812 | 43.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 80 | $12,240 | $7,502 | 61.3% |
| 11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | Facility | 2023 | 21 | 224 | $11,748 | $4,410 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 61 | $7,320 | $4,046 | 55.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 17 | 17 | $4,033 | $1,726 | 42.8% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Facility | 2023 | 23 | 41 | $3,905 | $1,134 | 29.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 17 | 17 | $2,805 | $1,044 | 37.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,155 | $791.23 | 68.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $448.00 | $411.04 | 91.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 27 | $351.00 | $193.85 | 55.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 98 | 460 | $54,290 | $23,153 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 81 | 282 | $47,520 | $21,411 | 45.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 61 | 228 | $34,292 | $20,218 | 59.0% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 77 | 355 | $95,140 | $16,344 | 17.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 98 | 232 | $27,174 | $13,450 | 49.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 64 | 70 | $20,650 | $11,308 | 54.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 98 | $16,345 | $8,364 | 51.2% |
| 11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | Facility | 2022 | 19 | 176 | $7,431 | $3,645 | 49.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 31 | 31 | $6,923 | $3,145 | 45.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,668 | $1,587 | 59.5% |
About Dr. Jane Emerick, M.D
Dr. Jane Emerick, M.D is a Infectious Disease healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053307066.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jane Emerick, M.D has received a total of $5,479 in payments from pharmaceutical and medical device companies, with $735.60 received in 2024. These payments were reported across 280 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,279).
As a Medicare-enrolled provider, Emerick has provided services to 2,684 Medicare beneficiaries, totaling 8,348 services with total Medicare billing of $490,546. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Westerville, OH
- Active Since 09/26/2005
- Last Updated 07/26/2018
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053307066
Products in Payments
- GRAFIX PL (Medical Supply) $623.58
- Puraply (Medical Supply) $480.42
- DALVANCE (Drug) $451.00
- Apligraf (Biological) $355.14
- Apligraf (Device) $333.50
- Puraply Antimicrobial (Medical Supply) $254.95
- DOVATO (Drug) $224.40
- VIBATIV (Drug) $209.55
- TEFLARO (Drug) $172.19
- Baxdela (Drug) $170.87
- DIFICID (Drug) $159.97
- Arikayce (Drug) $132.82
- VAC VERAFLO (Device) $126.72
- COLLAGENASE SANTYL (Drug) $123.45
- ZERBAXA (Drug) $114.29
- ISENTRESS (Drug) $104.76
- Kerecis Omega3 SurgiClose (Device) $91.28
- VOWST (Biological) $81.29
- Orbactiv (Drug) $69.78
- REGRANEX (Drug) $65.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Westerville
Steven Bobula, Md, MD
Infectious Disease — Payments: $48,979
Infectious Disease $48,979
Dr. Sunil Bhat, Md, MD
Infectious Disease — Payments: $2,897
Infectious Disease $2,897
Johnny Huh, M.d, M.D
Infectious Disease — Payments: $2,182
Infectious Disease $2,182
Timothy Anderson, Md, MD
Infectious Disease — Payments: $1,491
Infectious Disease $1,491
Wael Haidar, Md, MD
Infectious Disease — Payments: $340.27
Infectious Disease $340.27